Revisiting prostacyclin: New directions in pulmonary fibrosis and inflammation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 291, Issue 2, 2006, Pages

  Soberman, Roy J ^a   Christmas, Peter ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN; CYCLOOXYGENASE 2; ICOSANOID; INTERLEUKIN 6; LEUKOTRIENE; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROSTACYCLIN RECEPTOR; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN E2 SYNTHASE 1; PROSTAGLANDIN SYNTHASE; THROMBOXANE; UNCLASSIFIED DRUG;

ARTHRITIS; CELL PROLIFERATION; DISEASE SEVERITY; EDITORIAL; ENZYME SYNTHESIS; FIBROBLAST; HUMAN; INFLAMMATION; LIPOGENESIS; LUNG FIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOCYTE AGGREGATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; DINOPROSTONE; EPOPROSTENOL; INFLAMMATION; MICE; PULMONARY FIBROSIS;

EID: 33746599443     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00102.2006     Document Type: Editorial

References (12)

1. Bonner JC, Rice AB, Ingram JL, Moomaw CR, Nyska A, Bradbury A, Sessoms AR, Chulada PC, Morgan DL, Zeldin DC, and Langenbach R. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol 161: 459-470, 2002.
2. Bull TM. New and future therapies in pulmonary arterial hypertension. Semin Respir Crit Care Med 26: 429-436, 2005.
3. Gomberg-Maitland M and Preston IR. Prostacyclin therapy for pulmonary arterial hypertension: new directions. Semin Respir Crit Care Med 26: 394-401, 2005.
4. 2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 203: 325-335, 2006.
5. 2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am J Respir Cell Mol Biol 27:752-758, 2002.
6. Kern Lovgren A, Jania LA, Hartney JM, Parsons KK, Audoly LP, FitzGerald GA, Tilley SL, and Koller BH. COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 291: L144-L156, 2006.
7. Moore BB, Coffey MJ, Christensen P, Sitterding S, Ngan R, Wilke CA, McDonald R, Phare SM, Peters-Golden M, Paine R III, and Toews GB. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J Immunol 165: 4032-4039, 2000.
8. 2. Am J Physiol Lung Cell Mol Physiol 284: L342-L349, 2003.
9. Moore BB and Peters-Golden M. Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am J Respir Cell Mol Biol 32: 135-141, 2005.
10. 2. J Immunol 174: 5644-5649, 2005.
11. Peters-Golden M, Bailie M, Marshall T, Wilke C, Phan SH, Toews GB, and Moore BB. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 165: 229-235, 2002.
12. 2 and to express cyclooxygenase-2. J Clin Invest 95: 1861-1868, 1995.